PUBLISHER: The Business Research Company | PRODUCT CODE: 1947084
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947084
Rigid endoscopic lithotripsy devices are specialized medical instruments used to fragment kidney stones or other calculi in the urinary tract during minimally invasive procedures. Inserted through a rigid endoscope, they use energy sources such as lasers, ultrasound, or pneumatic force to break stones into smaller pieces for easier extraction or natural passage.
The main types of rigid endoscopic lithotripsy devices include ultrasonic lithotripsy, ballistic lithotripsy, electrohydraulic lithotripsy, and laser lithotripsy. Ultrasonic lithotripsy utilizes high-frequency sound waves to fragment kidney stones into smaller pieces that can be removed or naturally expelled. These devices are guided by procedures such as ureteroscopy, cystoscopy, and percutaneous nephrolithotomy and are used in hospitals, clinics, and ambulatory surgical centers for both adult and pediatric patients.
Tariffs have raised costs of imported lasers, rigid endoscopes, and accessories, affecting hospitals and clinics in North America and Asia-Pacific. Laser lithotripsy systems face the highest impact. Conversely, tariffs are supporting regional manufacturing and innovation in cost-effective lithotripsy devices.
The rigid endoscopic lithotripsy devices market research report is one of a series of new reports from The Business Research Company that provides rigid endoscopic lithotripsy devices market statistics, including rigid endoscopic lithotripsy devices industry global market size, regional shares, competitors with a rigid endoscopic lithotripsy devices market share, detailed rigid endoscopic lithotripsy devices market segments, market trends and opportunities, and any further data you may need to thrive in the rigid endoscopic lithotripsy devices industry. This rigid endoscopic lithotripsy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The rigid endoscopic lithotripsy devices market size has grown strongly in recent years. It will grow from $4.3 billion in 2025 to $4.62 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing kidney stone incidence, adoption of endoscopic techniques, reduced surgical recovery time, urology procedure growth, hospital infrastructure expansion.
The rigid endoscopic lithotripsy devices market size is expected to see strong growth in the next few years. It will grow to $6.11 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to advancements in laser technologies, rising outpatient procedures, growing elderly population, increasing lifestyle-related stone disease, demand for precision urology tools. Major trends in the forecast period include growing preference for minimally invasive stone treatment, rising adoption of laser lithotripsy, increasing use in ambulatory surgical centers, focus on device miniaturization, growth in day-care urology procedures.
The rising incidence of bladder cancer is increasingly supporting the expansion of the rigid endoscopic lithotripsy device market going forward. Bladder cancer is a malignant tumor originating in the bladder lining and is commonly associated with symptoms such as blood in the urine, frequent urination, and pelvic discomfort. The incidence of bladder cancer is increasing due to greater exposure to carcinogens such as tobacco smoke, industrial chemicals, and environmental pollutants, along with aging populations and improved diagnostic capabilities. Rigid endoscopic lithotripsy devices are used to manage bladder stones and complications associated with bladder cancer, including obstruction and irritation, and to assist in removing residual tumors and reducing recurrence risk. For example, in March 2024, according to the Cancer Facts and Figures 2024 report published by the American Cancer Society, bladder cancer diagnoses in the United States were projected to rise from 81,180 new cases in 2022 to 83,190 cases in 2024. Consequently, the increasing incidence of bladder cancer is reinforcing growth in the rigid endoscopic lithotripsy device market.
The rising healthcare expenditure is expected to propel the growth of the rigid endoscopic lithotripsy device market going forward. Healthcare expenditure refers to the total financial resources spent on healthcare services, including medical treatments, hospital care, medications, and public health initiatives. Increasing healthcare expenditure is driven by the rising prevalence of chronic diseases that require long-term and costly treatment. Higher healthcare spending supports adoption of rigid endoscopic lithotripsy devices by enabling hospitals and clinics to invest in advanced surgical equipment and expand access to minimally invasive procedures. For example, in May 2024, according to the Office for National Statistics, total healthcare expenditure in the UK increased by 5.6% in nominal terms in 2023, representing a 0.9% growth compared to 2022. Therefore, rising healthcare expenditure is driving growth of the rigid endoscopic lithotripsy device market.
Major companies operating in the rigid endoscopic lithotripsy devices market are pursuing strategic collaborations to enhance product innovation and broaden market reach. Strategic collaboration involves companies combining complementary resources and expertise to achieve shared objectives. For instance, in May 2023, Karl Storz SE & Co. KG, a Germany-based medical technology company, partnered with Well Lead Medical Co. Ltd., a China-based medical catheter provider, to advance endourology solutions and improve patient care outcomes. This partnership offers the ClearPetra suction-evacuation ureteral access sheath alongside KARL STORZ endoscopic visualization systems for comprehensive urinary stone management and includes an exclusive US distribution agreement for the ClearPetra Stone-Removal System.
Major companies operating in the rigid endoscopic lithotripsy devices market are EDAP TMS S.A., Boston Scientific Corporation, Olympus Corporation, Karl Storz SE & Co. KG, Cook Group Incorporated, ConMed Corporation, Richard Wolf GmbH, Dornier MedTech GmbH, EMS Electro Medical Systems S.A., Rocamed S.A.M., Elmed Medical Systems, LISA Laser Products, Jena MedTech GmbH, Biolitec AG, Medispec Ltd., DirexGroup, NOVAmedtek LLC, Walz Elektronik GmbH, Quanta System S.p.A., Convergent Laser Technologies, Storz Medical AG, Shenzhen Hyde Medical Equipment Co. Ltd, Advin Urology
North America was the largest region in the rigid endoscopic lithotripsy devices market in 2025. The regions covered in the rigid endoscopic lithotripsy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the rigid endoscopic lithotripsy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The rigid endoscopic lithotripsy devices market consists of sales of pneumatic lithotripters, mechanical fragmentors, combination lithotripters, fiber-optic endoscopes, and suction and irrigation systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Rigid Endoscopic Lithotripsy Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses rigid endoscopic lithotripsy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for rigid endoscopic lithotripsy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rigid endoscopic lithotripsy devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.